1. Origins, genetic landscape, and emerging therapies of small cell lung cancer
   Ekaterina A. Semenova et al, 2015, Genes & Development CrossRef
2. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib
   Cyril Sobolewski et al, 2021, Biomolecules CrossRef
3. Cisplatin‐resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib
   Lihong Wang et al, 2017, Molecular Oncology CrossRef
4. c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2
   Tze-chen Hsieh et al, 2019, Resveratrol - Adding Life to Years, Not Adding Years to Life CrossRef
5. Dual-target kinase drug design: Current strategies and future directions in cancer therapy
   Dejuan Sun et al, 2020, European Journal of Medicinal Chemistry CrossRef
6. Combinatorial BRD4 and AURKA inhibition is synergistic against preclinical models of Ewing sarcoma
   Laura Tomino et al, 2019, Cancer Reports CrossRef
7. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors
   Pankita H. Pandya et al, 2022, Cancers CrossRef
8. Dual Inhibition of PDK1 and Aurora Kinase A: An Effective Strategy to Induce Differentiation and Apoptosis of Human Glioblastoma Multiforme Stem Cells
   Simona Daniele et al, 2017, ACS Chemical Neuroscience CrossRef
9. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer
   Vladislav Korobeynikov et al, 2019, Breast Cancer Research and Treatment CrossRef
10. Palmatine induces G2/M phase arrest and mitochondrial-associated pathway apoptosis in colon cancer cells by targeting AURKA
    Xiaojiang Liu et al, 2020, Biochemical Pharmacology CrossRef
11. Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma
    Khandker Mohammad Khalid et al, 2024, Frontiers in Oncology CrossRef
12. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1
    Lihong Wang-Bishop et al, 2019, Gastroenterology CrossRef